QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 caribou-biosciences-cfo-jason-obyrne-informed-of-intent-to-resign-on-sept-1

- Reuters 

 hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-9-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

 caribou-biosciences-announces-the-fda-has-granted-fast-track-designations-to-cb-010-in-refractory-sle-and-to-cb-012-in-relapsed-or-refractory-aml

-- Fast Track designation is designed to expedite clinical development and regulatory review timelines -- -- Additional FDA des...

 hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-9-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

 rbc-capital-reiterates-outperform-on-caribou-biosciences-maintains-14-price-target

RBC Capital analyst Luca Issi reiterates Caribou Biosciences (NASDAQ:CRBU) with a Outperform and maintains $14 price target.

 caribou-biosciences-q2-eps-042-beats-045-estimate-sales-346m-beat-304m-estimate

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $...

 hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-9-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $9 price ...

 caribou-biosciences-discontinues-preclinical-research-on-allogeneic-car-nk-platform-reduces-workforce-by-21-positions-cost-containment-measures-to-extend-cash-runway-by-at-least-6-months-into-h2-2026

- Reuters 

 hc-wainwright--co-maintains-buy-on-caribou-biosciences-lowers-price-target-to-9

HC Wainwright & Co. analyst Robert Burns maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and lowers the price tar...

 attention-biotech-investors---stocks-to-watch-from-rbc-global-healthcare-conference

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...

 truist-securities-maintains-buy-on-caribou-biosciences-maintains-19-price-target

Truist Securities analyst Asthika Goonewardene maintains Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $19 pric...

 hc-wainwright--co-reiterates-buy-on-caribou-biosciences-maintains-24-price-target

HC Wainwright & Co. analyst Robert Burns reiterates Caribou Biosciences (NASDAQ:CRBU) with a Buy and maintains $24 price...

 caribou-biosciences-q1-eps-046-misses-040-estimate-sales-243m-miss-290m-estimate

Caribou Biosciences (NASDAQ:CRBU) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION